Dataset | Description | Positive | Negative
|
---|
| Dataset_1 | | |
Complete | This dataset contains 269 blood-brain barrier penetrating peptides sequences as positive dataset, and 269 cell-penetrating peptides as negative dataset. |  |  |
Training | This dataset contains 215 blood-brain barrier penetrating peptides sequences as positive dataset, and 215 cell-penetrating peptides as negative dataset. |  |  |
Validation | This dataset contains 54 blood-brain barrier penetrating peptides sequences as positive dataset, and 54 cell-penetrating peptides as negative dataset. |  |  |
| Dataset_2 | | |
Complete | This dataset contains 269 blood-brain barrier penetrating peptides sequences as positive dataset, and 269 non-blood-brain barrier penetrating peptides generated randomly from the Swiss-Prot database as negative dataset. |  |  |
Training | This dataset contains 215 blood-brain barrier penetrating peptides sequences as positive dataset, and 215 non-blood-brain barrier penetrating peptides generated randomly from the Swiss-Prot database as negative dataset. |  |  |
Validation | This dataset contains 54 blood-brain barrier penetrating peptides sequences as positive dataset, and 54 non-blood-brain barrier penetrating peptides generated randomly from the Swiss-Prot database as negative dataset. |  |  |
| Dataset_3 | | |
Complete | This dataset contains 269 blood-brain barrier penetrating peptides sequences as positive dataset, and 2690 non-blood-brain barrier penetrating peptides generated randomly from the Swiss-Prot database as negative dataset. |  |  |
Training | This dataset contains 215 blood-brain barrier penetrating peptides sequences as positive dataset, and 2152 non-blood-brain barrier penetrating peptides generated randomly from the Swiss-Prot database as negative dataset. |  |  |
Validation | This dataset contains 54 blood-brain barrier penetrating peptides sequences as positive dataset, and 538 non-blood-brain barrier penetrating peptides generated randomly from the Swiss-Prot database as negative dataset. |  |  |